Docekaas RTU is a ready-to-use injectable formulation of Docetaxel, a potent chemotherapy agent widely used to treat various cancers. The ready-to-use presentation enhances safety, accuracy, and convenience by eliminating the need for reconstitution, reducing preparation time and risk of dosing errors.

Available Strengths:

• 20 mg

• 80 mg

• 120 mg

Therapeutic Indications:

• Breast Cancer

• Non-Small Cell Lung Cancer (NSCLC)

• Prostate Cancer

• Gastric Cancer

• Head and Neck Cancers

Mechanism of Action:
Docetaxel promotes the assembly and stabilization of microtubules, preventing their disassembly, thereby inhibiting cell division and inducing apoptosis in cancer cells.

Key Features:

• Ready-to-use format minimizes preparation errors and contamination risks

• Manufactured in GMP-certified facilities ensuring high quality

• Sterile, prefilled vials for immediate administration

• Reduces handling time and enhances workflow efficiency in oncology centers

• Consistent potency and safety profile

Packaging:

• Sterile, ready-to-use solution in glass vials available in 20mg, 80mg, and 120mg doses

Storage:

Store 25°C -30°C. Protect from moisture and light. Keep out of reach of children.

Note: For intravenous use only. Administer under supervision of healthcare professionals experienced in chemotherapy administration.